CRISPR/Cas9

Afshin Abdi Ghavidel1, Shahin Aghamiri2, Pourya Raee3

  • 1Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Acta parasitologica
|December 21, 2023
PubMed
概括

克里斯普尔/卡斯9系统已成功适应Leishmania基因组操纵,使精确的基因编辑成为可能. 本综述详细介绍了方法和应用,包括疫苗开发和基因删除,推动了莱什曼尼亚研究.